Intrinsic Value of S&P & Nasdaq Contact Us

Bausch + Lomb Corporation BLCO NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • CA • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
$94.85
+467.6%
Analyst Price Target
$18.90
+13.1%

Bausch + Lomb Corporation (BLCO) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 7 Buy, 8 Hold, 1 Sell.

The consensus price target is $18.90 (low: $16.00, high: $21.00), representing an upside of 13.1% from the current price $16.71.

Analysts estimate Earnings Per Share (EPS) of $0.58 and revenue of $4.77B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.90 vs est $0.58 (missed -254.5%). 2025: actual $-1.02 vs est $0.53 (missed -292.8%). Analyst accuracy: 0%.

BLCO Stock — 12-Month Price Forecast

$18.90
▲ +13.11% Upside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Bausch + Lomb Corporation, the average price target is $18.90, with a high forecast of $21.00, and a low forecast of $16.00.
The average price target represents a +13.11% change from the last price of $16.71.
Highest Price Target
$21.00
Average Price Target
$18.90
Lowest Price Target
$16.00

BLCO Analyst Ratings

Hold
16
Ratings
7 Buy
8 Hold
1 Sell
Based on 16 analysts giving stock ratings to Bausch + Lomb Corporation in the past 3 months
Rating breakdown
Buy
7 44%
Hold
8 50%
Sell
1 6%
44%
Buy
7 analysts
50%
Hold
8 analysts
6%
Sell
1 analysts

EPS Estimates — BLCO

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.90 vs Est $0.58 ▼ 164.7% off
2025 Actual –$1.02 vs Est $0.53 ▼ 151.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

Revenue Estimates — BLCO

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $4.774B vs Est $4.769B ▲ 0.1% off
2025 Actual $5.101B vs Est $5.081B ▲ 0.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message